PolarityTE (PTEIQ) Competitors $0.11 0.00 (0.00%) (As of 12/20/2024 ET) Add Compare Share Share Competitors Stock AnalysisChartCompetitorsFinancialsSEC FilingsTrends PTEIQ vs. SNPX, APM, INM, HEPA, ATXI, CHRO, SNOA, PTIX, ONCO, and ARTLShould you be buying PolarityTE stock or one of its competitors? The main competitors of PolarityTE include Synaptogenix (SNPX), Aptorum Group (APM), InMed Pharmaceuticals (INM), Hepion Pharmaceuticals (HEPA), Avenue Therapeutics (ATXI), Chromocell Therapeutics (CHRO), Sonoma Pharmaceuticals (SNOA), Protagenic Therapeutics (PTIX), Onconetix (ONCO), and Artelo Biosciences (ARTL). These companies are all part of the "pharmaceutical products" industry. PolarityTE vs. Synaptogenix Aptorum Group InMed Pharmaceuticals Hepion Pharmaceuticals Avenue Therapeutics Chromocell Therapeutics Sonoma Pharmaceuticals Protagenic Therapeutics Onconetix Artelo Biosciences PolarityTE (NASDAQ:PTEIQ) and Synaptogenix (NASDAQ:SNPX) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their community ranking, valuation, dividends, media sentiment, analyst recommendations, institutional ownership, earnings, risk and profitability. Do institutionals and insiders believe in PTEIQ or SNPX? 11.8% of PolarityTE shares are held by institutional investors. Comparatively, 10.3% of Synaptogenix shares are held by institutional investors. 5.4% of PolarityTE shares are held by insiders. Comparatively, 2.7% of Synaptogenix shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth. Which has more volatility & risk, PTEIQ or SNPX? PolarityTE has a beta of 0.92, suggesting that its share price is 8% less volatile than the S&P 500. Comparatively, Synaptogenix has a beta of 1.18, suggesting that its share price is 18% more volatile than the S&P 500. Does the media favor PTEIQ or SNPX? In the previous week, Synaptogenix had 1 more articles in the media than PolarityTE. MarketBeat recorded 1 mentions for Synaptogenix and 0 mentions for PolarityTE. PolarityTE's average media sentiment score of 0.00 equaled Synaptogenix'saverage media sentiment score. Company Overall Sentiment PolarityTE Neutral Synaptogenix Neutral Does the MarketBeat Community favor PTEIQ or SNPX? Synaptogenix received 2 more outperform votes than PolarityTE when rated by MarketBeat users. CompanyUnderperformOutperformPolarityTEN/AN/ASynaptogenixOutperform Votes266.67% Underperform Votes133.33% Do analysts rate PTEIQ or SNPX? Synaptogenix has a consensus target price of $14.00, indicating a potential upside of 356.03%. Given Synaptogenix's stronger consensus rating and higher possible upside, analysts plainly believe Synaptogenix is more favorable than PolarityTE.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score PolarityTE 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Synaptogenix 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00 Is PTEIQ or SNPX more profitable? Synaptogenix's return on equity of -42.14% beat PolarityTE's return on equity.Company Net Margins Return on Equity Return on Assets PolarityTEN/A -106.08% -76.91% Synaptogenix N/A -42.14%-29.42% Which has preferable earnings & valuation, PTEIQ or SNPX? Synaptogenix has lower revenue, but higher earnings than PolarityTE. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioPolarityTE$810K1.00-$7.83M-$3.28-0.03SynaptogenixN/AN/A-$6.04MN/AN/A SummarySynaptogenix beats PolarityTE on 9 of the 12 factors compared between the two stocks. Ad Crypto Swap ProfitsURGENT: This Altcoin Opportunity Won’t Wait – Act NowIt’s here. This is the moment we’ve been waiting for. The next 3-6 months in crypto will be absolutely life-changing for those who are prepared. Why? Because altcoin prices are about to explode.>> Register for the Workshop Now Get PolarityTE News Delivered to You Automatically Sign up to receive the latest news and ratings for PTEIQ and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart PTEIQ vs. The Competition Export to ExcelMetricPolarityTEBiotechnology IndustryMedical SectorNASDAQ ExchangeMarket Cap$615,000.00$165.68M$5.14B$9.08BDividend YieldN/A3.64%5.09%4.23%P/E Ratio-0.03115.5190.1317.19Price / Sales1.0018,531.021,116.25117.05Price / CashN/A12.8743.1037.85Price / Book0.058.594.784.78Net Income-$7.83M-$20.67M$120.31M$225.60M7 Day Performance-16.65%-1.05%-1.92%-1.23%1 Month Performance-11.90%174.77%13.65%0.46%1 Year PerformanceN/A134.18%28.34%15.24% PolarityTE Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)PTEIQPolarityTEN/A$0.11flatN/A+18.1%$615,000.00$810,000.00-0.0360Gap UpSNPXSynaptogenix1.3915 of 5 stars$2.77+3.0%$14.00+406.3%-54.5%$3.76MN/A0.004News CoverageAPMAptorum Group0.3987 of 5 stars$0.72-6.5%N/A-66.2%$3.73M$431,378.000.0030News CoverageGap DownINMInMed Pharmaceuticals0.4358 of 5 stars$5.19-1.3%N/A-36.5%$3.73M$4.96M-0.3813News CoveragePositive NewsGap DownHEPAHepion PharmaceuticalsN/A$0.53-10.2%N/A-84.4%$3.69MN/A-0.1320ATXIAvenue Therapeutics2.1972 of 5 stars$1.74-3.3%N/A-83.3%$3.57MN/A0.094CHROChromocell TherapeuticsN/A$0.59+1.7%N/AN/A$3.56MN/A0.004SNOASonoma Pharmaceuticals0.5922 of 5 stars$2.65-0.7%N/A+1,608.9%$3.55M$13.55M-0.53180PTIXProtagenic Therapeutics0.8347 of 5 stars$0.52+4.0%N/A-27.7%$3.50MN/A-0.411Positive NewsGap UpONCOOnconetix0.1436 of 5 stars$0.42+5.0%N/AN/A$3.48M$1.87M0.0012ARTLArtelo Biosciences2.072 of 5 stars$1.06-4.5%$5.50+418.9%-31.3%$3.42MN/A-0.375News Coverage Related Companies and Tools Related Companies Synaptogenix Competitors Aptorum Group Competitors InMed Pharmaceuticals Competitors Hepion Pharmaceuticals Competitors Avenue Therapeutics Competitors Chromocell Therapeutics Competitors Sonoma Pharmaceuticals Competitors Protagenic Therapeutics Competitors Onconetix Competitors Artelo Biosciences Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:PTEIQ) was last updated on 12/22/2024 by MarketBeat.com Staff From Our PartnersThis Crypto Is Set to Explode in DecemberIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredWARNING: “Buffett Indicator” flashing for first time in 50 yearsWarren Buffett has sold a staggering $97 billion worth of stocks this year... But why? Our research indi...Behind the Markets | SponsoredYour bank is lying to you.You might think you have your money in a high-yield savings account, but do you really? The national average A...MyBankTracker | SponsoredRare "crisis signal" triggers for third time in U.S. marketA rare pattern has just repeated for the third time in U.S. history. The last two times this happened, the...Stansberry Research | SponsoredCould This Tiny Device Help You Make an Extra $30k a Year?I believe it’s going to power Elon Musk’s next AI revolution… A revolution he believes will be worth more t...Brownstone Research | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | SponsoredHOTTEST TRADER IN AMERICA 🔥🔥🔥Ready for a rocket ride this weekend? After alerting his readers to a tiny $2 stock called Bright Minds Bio...Timothy Sykes | SponsoredBuffett's Oil Bet + This 22% Dividend PlayWarren Buffett has been quietly amassing a massive position in oil stocks. But while Buffett's picks (Occid...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding PolarityTE, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share PolarityTE With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free PTEIQ Stock Alerts